Contact
searchSearch
HMP Global
Login

Depression Topic Center

A person completes a puzzle of a profile of a head, with a piece missing from where the brain is located.
News
Review Finds Little Consensus on Treatment-Resistant Depression in Real World
01/02/2025
Recent studies investigating the real-world experience of patients with treatment-resistant depression (TRD) are scarce, according to findings from a systematic literature review published in Advances in Therapy.
Recent studies investigating the real-world experience of patients with treatment-resistant depression (TRD) are scarce, according to findings from a systematic literature review published in Advances in Therapy.
Recent studies investigating the...
01/02/2025
Psych Congress Network
Pop quiz written on a blackboard with white chalk
Quiz
Antidepressant Discontinuation Symptoms
12/23/2024
Test your knowledge with this quick quiz!
Test your knowledge with this quick quiz!
Test your knowledge with this...
12/23/2024
Psych Congress Network
Are men or women more affected by depressive episodes?
Quiz
Are men or women more affected by depressive episodes?
12/17/2024
Pop quiz!
Pop quiz!
Pop quiz!
12/17/2024
Psych Congress Network
A doctor examines a patient who has a head injury from soccer
News
Concussion With Depression Worsens Symptoms, Brain Connectivity
11/15/2024
The comorbidity of depression and sports-related concussion amplifies symptoms of both conditions, according to study findings published in Brain Research.
The comorbidity of depression and sports-related concussion amplifies symptoms of both conditions, according to study findings published in Brain Research.
The comorbidity of depression...
11/15/2024
Psych Congress Network
Bright Light Therapy Effective for Depressive Disorders, May Improve Treatment Response Time
News
Bright Light Therapy Effective for Depressive Disorders, May Improve Treatment Response Time
10/09/2024
Bright light therapy (BLT) may be an effective adjunctive treatment for non-seasonal depressive disorders and improve response time for the initial treatment, according to results from a recent systematic review and meta-analysis published in...
Bright light therapy (BLT) may be an effective adjunctive treatment for non-seasonal depressive disorders and improve response time for the initial treatment, according to results from a recent systematic review and meta-analysis published in...
Bright light therapy (BLT) may...
10/09/2024
Psych Congress Network
Three illustrated faces, one sad, one neutral, one happy.
News
Psilocybin Shows Potential for Depression Treatment, Meta-Analysis Finds
10/03/2024
High-dose psilocybin demonstrated an effect similar to escitalopram for the treatment of depressive symptoms in a recent systematic review and meta-analysis published in The BMJ.
High-dose psilocybin demonstrated an effect similar to escitalopram for the treatment of depressive symptoms in a recent systematic review and meta-analysis published in The BMJ.
High-dose psilocybin...
10/03/2024
Psych Congress Network
An elderly woman sits on a couch
News
Increasing Depression Symptoms in Older Adults Associated With Amyloid Accumulation
09/09/2024
Increasing depression symptoms in older adults were associated with early amyloid accumulation in regions responsible for emotional control, and may foretell later Alzheimer Disease (AD) development
Increasing depression symptoms in older adults were associated with early amyloid accumulation in regions responsible for emotional control, and may foretell later Alzheimer Disease (AD) development
Increasing depression symptoms...
09/09/2024
Psych Congress Network
A health care professional reviews paperwork while sitting at a desk in front of a computer
News
Added Remote Support for Antidepressant Discontinuation Offers Only Small Benefits
08/07/2024
Adding internet and phone support to a family practitioner review for possible discontinuation of long-term antidepressants provided small additional benefits.
Adding internet and phone support to a family practitioner review for possible discontinuation of long-term antidepressants provided small additional benefits.
Adding internet and phone...
08/07/2024
Psych Congress Network
Secondary Analysis Shows Which Patients With TRD Benefit Most From Ketamine
News
Secondary Analysis Shows Which Patients With TRD Benefit Most From Ketamine
07/24/2024
Ketamine was associated with greater treatment response than electroconvulsive therapy in patients with nonpsychotic treatment-resistant depression who had moderately severe or severe pretreatment symptoms and who initiated treatment as...
Ketamine was associated with greater treatment response than electroconvulsive therapy in patients with nonpsychotic treatment-resistant depression who had moderately severe or severe pretreatment symptoms and who initiated treatment as...
Ketamine was associated with...
07/24/2024
Psych Congress Network
One in 7 Patients Experience Antidepressant Discontinuation Symptoms, Study Says
News
One in 7 Patients Experience Antidepressant Discontinuation Symptoms, Study Says
07/22/2024
Including non-specific effects, approximately 15% or 1 in 6 to 7 patients experience antidepressant discontinuation symptoms, according to recent systematic review and meta-analysis results published in The Lancet Psychiatry. 
Including non-specific effects, approximately 15% or 1 in 6 to 7 patients experience antidepressant discontinuation symptoms, according to recent systematic review and meta-analysis results published in The Lancet Psychiatry. 
Including non-specific effects,...
07/22/2024
Psych Congress Network
an illustration of a person sitting on the ground looking dejected
News
Extended-Release Ketamine Tablets May Improve Safety and Tolerability in TRD Treatment
07/12/2024
Racemic ketamine administered as an extended-release tablet (R-107) may offer a treatment option with improved safety and tolerability for patients with treatment-resistant depression (TRD).
Racemic ketamine administered as an extended-release tablet (R-107) may offer a treatment option with improved safety and tolerability for patients with treatment-resistant depression (TRD).
Racemic ketamine administered as...
07/12/2024
Psych Congress Network

News

A person completes a puzzle of a profile of a head, with a piece missing from where the brain is located.
News
Review Finds Little Consensus on Treatment-Resistant Depression in Real World
01/02/2025
Recent studies investigating the real-world experience of patients with treatment-resistant depression (TRD) are scarce, according to findings from a systematic literature review published in Advances in Therapy.
Recent studies investigating the real-world experience of patients with treatment-resistant depression (TRD) are scarce, according to findings from a systematic literature review published in Advances in Therapy.
Recent studies investigating the...
01/02/2025
Psych Congress Network
A doctor examines a patient who has a head injury from soccer
News
Concussion With Depression Worsens Symptoms, Brain Connectivity
11/15/2024
The comorbidity of depression and sports-related concussion amplifies symptoms of both conditions, according to study findings published in Brain Research.
The comorbidity of depression and sports-related concussion amplifies symptoms of both conditions, according to study findings published in Brain Research.
The comorbidity of depression...
11/15/2024
Psych Congress Network
Bright Light Therapy Effective for Depressive Disorders, May Improve Treatment Response Time
News
Bright Light Therapy Effective for Depressive Disorders, May Improve Treatment Response Time
10/09/2024
Bright light therapy (BLT) may be an effective adjunctive treatment for non-seasonal depressive disorders and improve response time for the initial treatment, according to results from a recent systematic review and meta-analysis published in...
Bright light therapy (BLT) may be an effective adjunctive treatment for non-seasonal depressive disorders and improve response time for the initial treatment, according to results from a recent systematic review and meta-analysis published in...
Bright light therapy (BLT) may...
10/09/2024
Psych Congress Network
Three illustrated faces, one sad, one neutral, one happy.
News
Psilocybin Shows Potential for Depression Treatment, Meta-Analysis Finds
10/03/2024
High-dose psilocybin demonstrated an effect similar to escitalopram for the treatment of depressive symptoms in a recent systematic review and meta-analysis published in The BMJ.
High-dose psilocybin demonstrated an effect similar to escitalopram for the treatment of depressive symptoms in a recent systematic review and meta-analysis published in The BMJ.
High-dose psilocybin...
10/03/2024
Psych Congress Network
An elderly woman sits on a couch
News
Increasing Depression Symptoms in Older Adults Associated With Amyloid Accumulation
09/09/2024
Increasing depression symptoms in older adults were associated with early amyloid accumulation in regions responsible for emotional control, and may foretell later Alzheimer Disease (AD) development
Increasing depression symptoms in older adults were associated with early amyloid accumulation in regions responsible for emotional control, and may foretell later Alzheimer Disease (AD) development
Increasing depression symptoms...
09/09/2024
Psych Congress Network
A health care professional reviews paperwork while sitting at a desk in front of a computer
News
Added Remote Support for Antidepressant Discontinuation Offers Only Small Benefits
08/07/2024
Adding internet and phone support to a family practitioner review for possible discontinuation of long-term antidepressants provided small additional benefits.
Adding internet and phone support to a family practitioner review for possible discontinuation of long-term antidepressants provided small additional benefits.
Adding internet and phone...
08/07/2024
Psych Congress Network
Secondary Analysis Shows Which Patients With TRD Benefit Most From Ketamine
News
Secondary Analysis Shows Which Patients With TRD Benefit Most From Ketamine
07/24/2024
Ketamine was associated with greater treatment response than electroconvulsive therapy in patients with nonpsychotic treatment-resistant depression who had moderately severe or severe pretreatment symptoms and who initiated treatment as...
Ketamine was associated with greater treatment response than electroconvulsive therapy in patients with nonpsychotic treatment-resistant depression who had moderately severe or severe pretreatment symptoms and who initiated treatment as...
Ketamine was associated with...
07/24/2024
Psych Congress Network
One in 7 Patients Experience Antidepressant Discontinuation Symptoms, Study Says
News
One in 7 Patients Experience Antidepressant Discontinuation Symptoms, Study Says
07/22/2024
Including non-specific effects, approximately 15% or 1 in 6 to 7 patients experience antidepressant discontinuation symptoms, according to recent systematic review and meta-analysis results published in The Lancet Psychiatry. 
Including non-specific effects, approximately 15% or 1 in 6 to 7 patients experience antidepressant discontinuation symptoms, according to recent systematic review and meta-analysis results published in The Lancet Psychiatry. 
Including non-specific effects,...
07/22/2024
Psych Congress Network
an illustration of a person sitting on the ground looking dejected
News
Extended-Release Ketamine Tablets May Improve Safety and Tolerability in TRD Treatment
07/12/2024
Racemic ketamine administered as an extended-release tablet (R-107) may offer a treatment option with improved safety and tolerability for patients with treatment-resistant depression (TRD).
Racemic ketamine administered as an extended-release tablet (R-107) may offer a treatment option with improved safety and tolerability for patients with treatment-resistant depression (TRD).
Racemic ketamine administered as...
07/12/2024
Psych Congress Network
News
Perimenopausal Patients at Significant Risk For Depression Emergence
06/13/2024
Compared to those in the pre-menopause phase, perimenopausal patients are at a higher risk for depressive symptoms and diagnoses. Results from the systematic review and meta-analysis were published in The Journal of Affective...
Compared to those in the pre-menopause phase, perimenopausal patients are at a higher risk for depressive symptoms and diagnoses. Results from the systematic review and meta-analysis were published in The Journal of Affective...
Compared to those in the...
06/13/2024
Psych Congress Network
A teddy bear against a blue background wearing a mask and stethoscope.
News
Prenatal Glucocorticoid Exposure Linked With Increased Mental Disorder Risk
01/17/2025
Prenatal exposure to glucocorticoids was associated with an increased risk of some mental disorders at age 15, according to a study published in JAMA Network Open.
Prenatal exposure to glucocorticoids was associated with an increased risk of some mental disorders at age 15, according to a study published in JAMA Network Open.
Prenatal exposure to...
01/17/2025
Psych Congress Network
A child sleeps in bed on her stomach with her mouth hanging open
News
Loudness of Snoring May Indicate Greater Hyperactivity in Children and Adolescents
01/16/2025
Loudness of snoring, regardless of hypoxic burden and obstructive sleep apnea syndrome severity (OSAS), may contribute to hyperactivity in pediatric patients, according to an observational prospective study published in Sleep Medicine.
Loudness of snoring, regardless of hypoxic burden and obstructive sleep apnea syndrome severity (OSAS), may contribute to hyperactivity in pediatric patients, according to an observational prospective study published in Sleep Medicine.
Loudness of snoring, regardless...
01/16/2025
Psych Congress Network
Is it Time for a ‘Reconceptualization’ of TRD? Some Think Yes
News
Is it Time for a ‘Reconceptualization’ of TRD? Some Think Yes
01/14/2025
Treatment-resistant depression (TRD) may be a more complex and multifaceted condition than previously thought, with authors of a recent study calling for a “unified definition and reconceptualization” of the illness. Their findings were...
Treatment-resistant depression (TRD) may be a more complex and multifaceted condition than previously thought, with authors of a recent study calling for a “unified definition and reconceptualization” of the illness. Their findings were...
Treatment-resistant depression...
01/14/2025
Psych Congress Network
Veterans’ OUD Diagnoses Increased From 2005 to 2017, Then Declined
News
Veterans’ OUD Diagnoses Increased From 2005 to 2017, Then Declined
01/14/2025
The prevalence of OUD diagnoses increased from 2005 to 2017, peaked in 2017, and then declined until 2022, according to a recent cross-sectional study of national Veterans Health Administration (VHA) electronic health record data published in...
The prevalence of OUD diagnoses increased from 2005 to 2017, peaked in 2017, and then declined until 2022, according to a recent cross-sectional study of national Veterans Health Administration (VHA) electronic health record data published in...
The prevalence of OUD diagnoses...
01/14/2025
Psych Congress Network
News
Meta-Analysis Finds Little Support for Neurofeedback for ADHD
01/13/2025
Neurofeedback did not show meaningful clinical or neuropsychological benefit for individuals with attention-deficit/hyperactivity disorder (ADHD), according to results from a systematic review and meta-analysis published print in JAMA...
Neurofeedback did not show meaningful clinical or neuropsychological benefit for individuals with attention-deficit/hyperactivity disorder (ADHD), according to results from a systematic review and meta-analysis published print in JAMA...
Neurofeedback did not show...
01/13/2025
Psych Congress Network
US FDA sign
News
Posdinemab Granted Fast Track Designation by the FDA for Early Alzheimer Disease
01/10/2025
Posdinemab, a phosphorylated tau-directed monoclonal antibody (mAb) being studied for the treatment of early Alzheimer disease (AD), was granted Fast Track designation by the US Food and Drug Administration (FDA).
Posdinemab, a phosphorylated tau-directed monoclonal antibody (mAb) being studied for the treatment of early Alzheimer disease (AD), was granted Fast Track designation by the US Food and Drug Administration (FDA).
Posdinemab, a phosphorylated...
01/10/2025
Psych Congress Network
Minority of Patients With OUD Develop PW After Buprenorphine Initiation
News
Minority of Patients With OUD Develop PW After Buprenorphine Initiation
01/08/2025
A small group of patients with OUD developed buprenorphine-precipitated withdrawal (PW) in emergency department or hospital settings, according to recent retrospective cohort study results published in JAMA Network Open.
A small group of patients with OUD developed buprenorphine-precipitated withdrawal (PW) in emergency department or hospital settings, according to recent retrospective cohort study results published in JAMA Network Open.
A small group of patients with...
01/08/2025
Psych Congress Network
Methylphenidate or Atomoxetine Maintenance Safe During Pregnancy
News
Methylphenidate or Atomoxetine Maintenance Safe During Pregnancy
01/08/2025
Maintenance of methylphenidate or atomoxetine may be safe during pregnancy, according to recent systematic review and meta-analysis results published in JAMA Network Open. 
Maintenance of methylphenidate or atomoxetine may be safe during pregnancy, according to recent systematic review and meta-analysis results published in JAMA Network Open. 
Maintenance of methylphenidate...
01/08/2025
Psych Congress Network
brain waves schizophrenia transcranial magnetic stimulation
News
Review Questions Utility of tDCS for Cognitive Symptoms in Schizophrenia
01/08/2025
A recent meta-analysis questions the effectiveness of transcranial direct current stimulation (tDCS) for improving cognitive impairments in individuals with schizophrenia after finding no statistically significant difference in cognitive...
A recent meta-analysis questions the effectiveness of transcranial direct current stimulation (tDCS) for improving cognitive impairments in individuals with schizophrenia after finding no statistically significant difference in cognitive...
A recent meta-analysis questions...
01/08/2025
Psych Congress Network
Major Depressive Disorder MDD
News
Hypomanic Symptoms in Major Depression Linked With Treatment Resistance
01/03/2025
Common in patients with unipolar depression, hypomanic symptoms are associated with both treatment-resistant depression and reduced remission of suicidal thoughts, according to a study in the Journal of Affective Disorders.
Common in patients with unipolar depression, hypomanic symptoms are associated with both treatment-resistant depression and reduced remission of suicidal thoughts, according to a study in the Journal of Affective Disorders.
Common in patients with unipolar...
01/03/2025
Psych Congress Network

Quizzes

Pop quiz written on a blackboard with white chalk
Quiz
Antidepressant Discontinuation Symptoms
12/23/2024
Test your knowledge with this quick quiz!
Test your knowledge with this quick quiz!
Test your knowledge with this...
12/23/2024
Psych Congress Network
Are men or women more affected by depressive episodes?
Quiz
Are men or women more affected by depressive episodes?
12/17/2024
Pop quiz!
Pop quiz!
Pop quiz!
12/17/2024
Psych Congress Network
Pop quiz written on a blackboard with white chalk
Quiz
Depression Treatment and Sexual Dysfunction
03/04/2024
Test your clinical knowledge with this quick quiz!
Test your clinical knowledge with this quick quiz!
Test your clinical knowledge...
03/04/2024
Psych Congress Network
Three illustrated faces, one sad, one neutral, one happy.
Quiz
Does air pollution impact postpartum depression risk?
01/08/2024
Test your psychiatry knowledge with this quiz!
Test your psychiatry knowledge with this quiz!
Test your psychiatry knowledge...
01/08/2024
Psych Congress Network
Pop quiz written on a blackboard with white chalk
Quiz
How does depression affect new mothers?
11/20/2023
Can you ace this psychiatry quiz?
Can you ace this psychiatry quiz?
Can you ace this psychiatry quiz?
11/20/2023
Psych Congress Network
Pencils spell out quiz.
Quiz
How does traumatic brain injury affect depression treatment?
09/25/2023
Test your psychiatry knowledge with this quick quiz!
Test your psychiatry knowledge with this quick quiz!
Test your psychiatry knowledge...
09/25/2023
Psych Congress Network
Quiz time!
Quiz
Which intervention is most effective for treatment-resistant depression?
05/07/2023
Test your psychiatry knowledge with this quick quiz!
Test your psychiatry knowledge with this quick quiz!
Test your psychiatry knowledge...
05/07/2023
Psych Congress Network
Three illustrated faces, one sad, one neutral, one happy.
Quiz
How can clinicians maximize the efficacy of second-line antidepressant treatment?
12/09/2022
Take the quiz to test your knowledge!
Take the quiz to test your knowledge!
Take the quiz to test your...
12/09/2022
Psych Congress Network
Quiz
Using Digital-CBT for Prenatal Insomnia
01/24/2022
According to new research, can digital CBT for prenatal insomnia help to prevent postpartum depression and anxiety?
According to new research, can digital CBT for prenatal insomnia help to prevent postpartum depression and anxiety?
According to new research, can...
01/24/2022
Psych Congress Network
Childhood Depression
Quiz
How does depression in childhood impact adulthood?
08/13/2021
What effect does childhood depression have on adulthood? Take the quiz to find out!
What effect does childhood depression have on adulthood? Take the quiz to find out!
What effect does childhood...
08/13/2021
Psych Congress Network
Quiz
Quiz
What percentage of people experience hypomanic symptoms during an MDD episode?
01/15/2025
According to a recent study published in the Journal of Affective Disorders, what percentage of people experienced hypomanic symptoms during a major depressive disorder (MDD) episode?
According to a recent study published in the Journal of Affective Disorders, what percentage of people experienced hypomanic symptoms during a major depressive disorder (MDD) episode?
According to a recent study...
01/15/2025
Psych Congress Network
Which U.S. region saw the most fentanyl pill seizures in 2023?
Quiz
Which US region saw the most fentanyl pill seizures in 2023?
01/15/2025
Do you remember the details of this study?
Do you remember the details of this study?
Do you remember the details of...
01/15/2025
Psych Congress Network
An illustration of a pencil marking answers on a quiz sheet.
Expert Insights Quiz
Resources for Telehealth Rules and Regulations
01/06/2025
Test your knowledge with this quiz!
Test your knowledge with this quiz!
Test your knowledge with this...
01/06/2025
Psych Congress Network
How long does worry need to be present in order to diagnose GAD?
Quiz
How long does worry need to be present in order to diagnose GAD?
01/03/2025
Test your diagnostic knowledge!
Test your diagnostic knowledge!
Test your diagnostic knowledge!
01/03/2025
Psych Congress Network
Pop quiz written on a blackboard with white chalk
Quiz
Antidepressant Discontinuation Symptoms
12/23/2024
Test your knowledge with this quick quiz!
Test your knowledge with this quick quiz!
Test your knowledge with this...
12/23/2024
Psych Congress Network
Four people ponder with question marks over their heads
Quiz
Prodromal Symptoms in Schizophrenia
12/18/2024
Test your knowledge with this quick quiz!
Test your knowledge with this quick quiz!
Test your knowledge with this...
12/18/2024
Psych Congress Network
Are men or women more affected by depressive episodes?
Quiz
Are men or women more affected by depressive episodes?
12/17/2024
Pop quiz!
Pop quiz!
Pop quiz!
12/17/2024
Psych Congress Network
After how many months is 'problematic' opioid use diagnosed as OUD?
Quiz
After how many months is 'problematic' opioid use diagnosed as OUD?
12/16/2024
Test your diagnostic knowledge!
Test your diagnostic knowledge!
Test your diagnostic knowledge!
12/16/2024
Psych Congress Network
DSM-5
Quiz
How does the DSM-5 define 'remission' in MDD?
12/13/2024
Quiz! What is the definition of remission in the context of major depressive disorder (MDD), according to the DSM-5-TR?
Quiz! What is the definition of remission in the context of major depressive disorder (MDD), according to the DSM-5-TR?
Quiz! What is the definition of...
12/13/2024
Psych Congress Network
DSM-5
Quiz
How does the chronicity of depressive symptoms affect MDD treatment and outcomes?
12/11/2024
12/11/2024
Psych Congress Network

Insights

Rakesh Jain, MD, MPH.
Videos
Approaching Psychedelics for Depression With Both Caution and Optimism
02/06/2024
Rakesh Jain, MD, MPH, explains when clinicians may need to be more cautious when weighing the benefits of psychedelic therapy for depression.
Rakesh Jain, MD, MPH, explains when clinicians may need to be more cautious when weighing the benefits of psychedelic therapy for depression.
Rakesh Jain, MD, MPH, explains...
02/06/2024
Psych Congress Network
Dr. Robin Carhart-Harris on the Power of Psychedelics
Videos
Dr. Robin Carhart-Harris on the Power of Psychedelics
07/22/2020
Robin Carhart-Harris, PhD, head of the Centre of Psychedelic Research at Imperial College London in England, discusses the power of psychedelics.
Robin Carhart-Harris, PhD, head of the Centre of Psychedelic Research at Imperial College London in England, discusses the power of psychedelics.
Robin Carhart-Harris, PhD, head...
07/22/2020
Psych Congress Network
Using Antipsychotics as an Adjunctive Therapy in Depression
Videos
Using Antipsychotics as an Adjunctive Therapy in Depression
03/19/2020
Michael Thase, MD, of the University of Pennsylvania, discusses the use of second-generation antipsychotics as an adjunctive therapy in depression.
Michael Thase, MD, of the University of Pennsylvania, discusses the use of second-generation antipsychotics as an adjunctive therapy in depression.
Michael Thase, MD, of the...
03/19/2020
Psych Congress Network
Videos
Detecting Mixed Features in Major Depression
12/05/2019
W. Clay Jackson, MD, DipTh, explains the difference between major depressive disorder and major depressive disorder with mixed features.
W. Clay Jackson, MD, DipTh, explains the difference between major depressive disorder and major depressive disorder with mixed features.
W. Clay Jackson, MD, DipTh,...
12/05/2019
Psych Congress Network
Videos
Best Practices for Administering Esketamine
11/07/2019
Sanjay J. Mathew, MD, speaks about best practices for administering esketamine during his Psych Congress 2019 presentation "Top 5 Issues Clinicians Should Know about Ketamine Therapy."
Sanjay J. Mathew, MD, speaks about best practices for administering esketamine during his Psych Congress 2019 presentation "Top 5 Issues Clinicians Should Know about Ketamine Therapy."
Sanjay J. Mathew, MD, speaks...
11/07/2019
Psych Congress Network
Blog
The Psychedelic Aspect of Esketamine is an Opportunity, Not a Side Effect
05/23/2019
BLOG: Esketamine represents the first psychedelic treatment approved by the FDA for a psychiatric condition.
BLOG: Esketamine represents the first psychedelic treatment approved by the FDA for a psychiatric condition.
BLOG: Esketamine represents the...
05/23/2019
Psych Congress Network
Videos
Detecting and Diagnosing Postpartum Depression
02/18/2019
In this video, Marlene Freeman, MD, discusses tools for detecting postpartum depression, how postpartum depression differs from other mental health disorders, and risk factors for postpartum depression.
In this video, Marlene Freeman, MD, discusses tools for detecting postpartum depression, how postpartum depression differs from other mental health disorders, and risk factors for postpartum depression.
In this video, Marlene Freeman,...
02/18/2019
Psych Congress Network
Videos
Detecting and Treating Severe Depression
02/11/2019
In this video, Mark Zimmerman, MD, discusses severe depression and how it differs from mild and moderate depression, and the signs and treatment of severe depression.
In this video, Mark Zimmerman, MD, discusses severe depression and how it differs from mild and moderate depression, and the signs and treatment of severe depression.
In this video, Mark Zimmerman,...
02/11/2019
Psych Congress Network
Andrew Penn
Blog
Defeating Depression by Reconnecting With Others and the World
11/30/2018
BLOG: This year’s Psych Congress returned, time and again, to the theme of us needing to reconnect with a larger experience of the world in order to find a path out of depression.
BLOG: This year’s Psych Congress returned, time and again, to the theme of us needing to reconnect with a larger experience of the world in order to find a path out of depression.
BLOG: This year’s Psych Congress...
11/30/2018
Psych Congress Network
Videos
Marlene Freeman, MD, Discusses EnBrace HR Study
11/14/2018
Marlene Freeman, MD, discusses her poster presented at Psych Congress 2018, "EnBrace HR for Depression Treatment and Prevention in Women Trying to Conceive and Early Pregnancy." Poster and video sponsored by JayMac Pharmaceuticals,...
Marlene Freeman, MD, discusses her poster presented at Psych Congress 2018, "EnBrace HR for Depression Treatment and Prevention in Women Trying to Conceive and Early Pregnancy." Poster and video sponsored by JayMac Pharmaceuticals,...
Marlene Freeman, MD, discusses...
11/14/2018
Psych Congress Network
Brooke Kempf
Videos
Addressing Misconceptions About LAI Antipsychotics
01/06/2025
Kempf emphasizes the power of patient education, addressing myths, and involving families to ease the daily medication burden. 
Kempf emphasizes the power of patient education, addressing myths, and involving families to ease the daily medication burden. 
Kempf emphasizes the power of...
01/06/2025
Psych Congress Network
Desiree Matthews, PMHNP-BC, CEO
Videos
How to Navigate Insurance When Treating Tardive Dyskinesia
01/06/2025
In this video, Desiree Matthews, PMHNP-BC, discusses how to navigate insurance policies when treating tardive dyskinesia.
In this video, Desiree Matthews, PMHNP-BC, discusses how to navigate insurance policies when treating tardive dyskinesia.
In this video, Desiree Matthews,...
01/06/2025
Psych Congress Network
Desiree Matthews, PMHNP-BC, CEO
Videos
How to Navigate Insurance When Treating Tardive Dyskinesia
01/06/2025
In this video, Desiree Matthews, PMHNP-BC, discusses how to navigate insurance policies when treating tardive dyskinesia.
In this video, Desiree Matthews, PMHNP-BC, discusses how to navigate insurance policies when treating tardive dyskinesia.
In this video, Desiree Matthews,...
01/06/2025
Psych Congress Network
Andrew Penn, PMHNP-BC
Videos
Best Practices for Deprescribing in Schizophrenia
12/05/2024
In this video, Andrew Penn, PMHNP-BC, NP, CNS, MS, RN offers some key clinical takeaways from his session on deprescribing and how it even has a place when treating patients living with serious mental illness like schizophrenia.
In this video, Andrew Penn, PMHNP-BC, NP, CNS, MS, RN offers some key clinical takeaways from his session on deprescribing and how it even has a place when treating patients living with serious mental illness like schizophrenia.
In this video, Andrew Penn,...
12/05/2024
Psych Congress Network
Rebecca Barbee, MSPAS, PA-C, CAQ-Psych
Videos
Understanding Antipsychotic-Induced Movement Disorders
12/05/2024
Rebecca Barbee, MSPAS, PA-C, CAQ-Psych, explains the differences between dystonia, akathisia, drug-induced Parkinsonism, and tardive dyskinesia, as well as the different management approaches for each.
Rebecca Barbee, MSPAS, PA-C, CAQ-Psych, explains the differences between dystonia, akathisia, drug-induced Parkinsonism, and tardive dyskinesia, as well as the different management approaches for each.
Rebecca Barbee, MSPAS, PA-C,...
12/05/2024
Psych Congress Network
Edward Kaftarian, MD.
Videos
How to Maintain Up-To-Date Telehealth Regulation Compliance
12/03/2024
Edward Kaftarian, MD, offers some practical tips for maintaining regulatory compliance while managing a busy telehealth practice.
Edward Kaftarian, MD, offers some practical tips for maintaining regulatory compliance while managing a busy telehealth practice.
Edward Kaftarian, MD, offers...
12/03/2024
Psych Congress Network
Dr Craig Chepke
Schizophrenia Conference Insights
Muscarinic Acetylcholine Receptors in Schizophrenia: A Shift From Dopamine D2 to Muscarinic Agonists
11/27/2024
In this video, Craig Chepke, MD, DFAPA, scientific director, Psych Congress, explains the vital differences between dopamine D2 receptor antipsychotics and muscarinic agonists for the treatment of schizophrenia, including mechanisms of action...
In this video, Craig Chepke, MD, DFAPA, scientific director, Psych Congress, explains the vital differences between dopamine D2 receptor antipsychotics and muscarinic agonists for the treatment of schizophrenia, including mechanisms of action...
In this video, Craig Chepke, MD,...
11/27/2024
Psych Congress Network
Edward Kaftarian, MD.
Videos
Major Changes to Telehealth Regulations May Be on the Horizon
11/25/2024
Edward Kaftarian, MD, explains possible upcoming changes to telehealth policy and practice.
Edward Kaftarian, MD, explains possible upcoming changes to telehealth policy and practice.
Edward Kaftarian, MD, explains...
11/25/2024
Psych Congress Network
3 roundtable participants
Videos
Overview of Anticholinergic Medications
11/25/2024
This roundtable video featuring Desiree Matthews, Jonathan Meyer, and Leslie Citrome provides background on the use of anticholinergic medications in psychiatry.
This roundtable video featuring Desiree Matthews, Jonathan Meyer, and Leslie Citrome provides background on the use of anticholinergic medications in psychiatry.
This roundtable video featuring...
11/25/2024
Psych Congress Network
3 roundtable participants
Videos
The Anticholinergic Burden of Psychotherapeutics
11/25/2024
This roundtable video featuring Desiree Matthews, Jonathan Meyer, and Leslie Citrome discusses the patient burden of anticholinergic drugs.
This roundtable video featuring Desiree Matthews, Jonathan Meyer, and Leslie Citrome discusses the patient burden of anticholinergic drugs.
This roundtable video featuring...
11/25/2024
Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Sign Up

Psych Congress Network Newsletter

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use